Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

Cited In for PubMed (Select 8299086)

1.

The construct of breast cancer risk perception: need for a better risk communication?

de Jonge ET, Vlasselaer J, Van de Putte G, Schobbens JC.

Facts Views Vis Obgyn. 2009;1(2):122-9. Review.

2.

The safety parameters of the study on intraductal cytotoxic agent delivery to the breast before mastectomy.

Zhang B, Love SM, Chen G, Wang J, Gao J, Xu X, Wang Z, Wang X.

Chin J Cancer Res. 2014 Oct;26(5):579-87. doi: 10.3978/j.issn.1000-9604.2014.10.06.

3.

Pathogenesis, prevention, diagnosis and treatment of breast cancer.

Shah R, Rosso K, Nathanson SD.

World J Clin Oncol. 2014 Aug 10;5(3):283-98. doi: 10.5306/wjco.v5.i3.283. Review.

4.

Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population.

Lee CP, Irwanto A, Salim A, Yuan JM, Liu J, Koh WP, Hartman M.

Breast Cancer Res. 2014 Jun 18;16(3):R64. doi: 10.1186/bcr3678.

5.

Hereditary cancer risk assessment: essential tools for a better approach.

Gomy I, Estevez Diz Mdel P.

Hered Cancer Clin Pract. 2013 Oct 28;11(1):16. doi: 10.1186/1897-4287-11-16.

6.

Breast cancer in the young: role of the geneticist.

Woodson AH, Profato JL, Muse KI, Litton JK.

J Thorac Dis. 2013 Jun;5 Suppl 1:S19-26. doi: 10.3978/j.issn.2072-1439.2013.04.13.

7.

Multiple bilateral circumscribed masses at screening breast US: consider annual follow-up.

Berg WA, Zhang Z, Cormack JB, Mendelson EB.

Radiology. 2013 Sep;268(3):673-83. doi: 10.1148/radiol.13122251. Epub 2013 Apr 24.

8.

Beyond mammography: new frontiers in breast cancer screening.

Drukteinis JS, Mooney BP, Flowers CI, Gatenby RA.

Am J Med. 2013 Jun;126(6):472-9. doi: 10.1016/j.amjmed.2012.11.025. Epub 2013 Apr 3. Review.

9.

Using a state cancer registry to recruit young breast cancer survivors and high-risk relatives: protocol of a randomized trial testing the efficacy of a targeted versus a tailored intervention to increase breast cancer screening.

Katapodi MC, Northouse LL, Schafenacker AM, Duquette D, Duffy SA, Ronis DL, Anderson B, Janz NK, McLosky J, Milliron KJ, Merajver SD, Duong LM, Copeland G.

BMC Cancer. 2013 Mar 1;13:97. doi: 10.1186/1471-2407-13-97.

10.

Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.

Culver JO, Brinkerhoff CD, Clague J, Yang K, Singh KE, Sand SR, Weitzel JN.

Clin Genet. 2013 Nov;84(5):464-72. doi: 10.1111/cge.12097. Epub 2013 Feb 20.

11.

Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.

Quante AS, Whittemore AS, Shriver T, Strauch K, Terry MB.

Breast Cancer Res. 2012 Nov 5;14(6):R144. doi: 10.1186/bcr3352.

12.

Individual breast cancer risk assessment in underserved populations: integrating empirical bioethics and health disparities research.

Anderson EE, Hoskins K.

J Health Care Poor Underserved. 2012 Nov;23(4 Suppl):34-46. doi: 10.1353/hpu.2012.0178.

13.

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial.

Saadatmand S, Rutgers EJ, Tollenaar RA, Zonderland HM, Ausems MG, Keymeulen KB, Schlooz-Vries MS, Koppert LB, Heijnsdijk EA, Seynaeve C, Verhoef C, Oosterwijk JC, Obdeijn IM, de Koning HJ, Tilanus-Linthorst MM.

BMC Cancer. 2012 Oct 2;12:440. doi: 10.1186/1471-2407-12-440.

14.

Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer.

Ståhlbom AK, Johansson H, Liljegren A, von Wachenfeldt A, Arver B.

Fam Cancer. 2012 Mar;11(1):33-40. doi: 10.1007/s10689-011-9495-1.

15.

Breast cancer genetic counselling referrals: how comparable are the findings between the UK and the Netherlands?

Albada A, Werrett J, Van Dulmen S, Bensing JM, Chapman C, Ausems MG, Metcalfe A.

J Community Genet. 2011 Dec;2(4):233-47. doi: 10.1007/s12687-011-0061-1. Epub 2011 Aug 18.

16.

Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany.

Gadzicki D, Evans DG, Harris H, Julian-Reynier C, Nippert I, Schmidtke J, Tibben A, van Asperen CJ, Schlegelberger B.

J Community Genet. 2011 Jun;2(2):53-69. doi: 10.1007/s12687-011-0042-4. Epub 2011 Mar 2.

17.

Genetics for the general internist.

Laukaitis CM.

Am J Med. 2012 Jan;125(1):7-13. doi: 10.1016/j.amjmed.2011.07.034. Epub 2011 Nov 11. Review.

18.

Breast cancer risk assessment in 64,659 women at a single high-volume mammography clinic.

Brinton JT, Barke LD, Freivogel ME, Jackson S, O'Donnell CI, Glueck DH.

Acad Radiol. 2012 Jan;19(1):95-9. doi: 10.1016/j.acra.2011.09.003. Epub 2011 Nov 3.

19.

Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer.

Kossman DA, Williams NI, Domchek SM, Kurzer MS, Stopfer JE, Schmitz KH.

J Appl Physiol (1985). 2011 Dec;111(6):1687-93. doi: 10.1152/japplphysiol.00319.2011. Epub 2011 Sep 8.

20.

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.

Weitzel JN, Blazer KR, Macdonald DJ, Culver JO, Offit K.

CA Cancer J Clin. 2011 Aug 19. doi: 10.3322/caac.20128. [Epub ahead of print]

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk